ONE Bio Signs U.S. Distribution Agreement
03 February 2011 - 12:00AM
Marketwired
ONE Bio, Corp. ("ONE" or the "Company")
(OTCBB: ONBI), an innovative company utilizing green process
manufacturing to produce raw chemicals and herbal extracts, natural
and health supplements and organic products, announced today that
its subsidiary, Green Planet Bioengineering Co., Ltd., has signed a
U.S. distribution agreement with P&G Ingredient, LLC
("P&G"), a producer and distributor of botanical and chemical
extracts.
The agreement includes pre-orders for the Company's raw
extracts, including resveratrol, stevia leaf powder, 5-HTP,
polygonum extract and spirulina powder. Headquartered in New Jersey
and operating for over a decade, P&G is a producer in the
botanical and chemical extracts field, with product distribution
that ranges from raw botanicals and chemical ingredients to API
(Active Pharmaceutical Ingredients) and ANI (Active Natural
Ingredients).
"This agreement is an important part of our strategy to expand
distribution of our highly sought-after raw chemicals and herbal
extracts in the United States," stated ONE's CEO, Marius Silvasan.
"Our sales strategy for 2011 is focused on expanding our
distribution in three key markets: the U.S., China and Japan. The
New Jersey/New York region is a strategic entry point in the U.S.,
as it has the largest concentration of botanical extract and
ingredient distributors in the nation. New Jersey is also home to
five foreign-trade zones that allow companies involved in
international trade to cut, delay or eliminate customs charges,
which will increase the competitiveness of our products."
Mr. Silvasan continued, "We have achieved much success in China
and Japan and are well positioned for aggressive U.S. expansion
this year. In our aging society, a growing number of American
consumers are seeking to maintain a healthy lifestyle focused on
alternative medicines and preventative care. These key factors will
continue to drive increased sales of nutraceutical and
health-related products, including organic food products."
"For the first nine months of 2010 25% of our revenue was
derived outside of China," continued Mr. Silvasan. "We expect sales
outside of China to account for a greater percentage of our total
revenue in 2011 as we expand our business in the U.S."
About ONE Bio, Corp. ONE Bio, Corp.
("ONE") (OTCBB: ONBI) (www.onehcorp.com), headquartered in Miami,
FL, with manufacturing facilities in China, is an innovative
company utilizing patented green process manufacturing to produce
raw chemicals and herbal extracts, natural supplements and organic
products. ONE is focused on the Asia Pacific region and the Unites
States. Key products include widely recognized Solanesol, CoQ10,
Resveratrol and 5-HTP, organic fertilizers, and organic bamboo
health food and beverages. ONE has experienced solid organic growth
driven by a robust demand for its products in China, Japan and the
United States.
This press release includes statements that constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE
Bio, Corp. claims the protection of the safe-harbor for
forward-looking statements contained in the Reform Act. These
forward-looking statements are often characterized by the terms
"may," "believes," "projects," "expects," or "anticipates," and do
not reflect historical facts. Specific forward-looking statements
contained in this press release include, but are not limited to:
our successful integration of diversified growth companies, impact
of the company's expansion plan, and new business development
success, future financial results, development and acquisition of
new product lines and services, the impact of competitive products
or pricing from technological changes, the effect of economic
conditions and other uncertainties. The forward-looking statements
contained herein involve risks and uncertainties that could cause
actual results to differ materially from the expectations contained
in any such forward-looking statements. These risks include, but
are not limited to: failure to manage operating expenses or
integrate new companies and/or technologies, each of which could
have a material impact on our business, our financial results, and
the company's stock price. These risks and other factors are
detailed in the Company's regular filings with the U.S. Securities
and Exchange Commission. Most of these factors are difficult to
predict accurately and are generally beyond the Company's control.
Forward-looking statements speak only as to the date they are made
and ONE Bio, Corp. does not undertake to update forward-looking
statements to reflect circumstances or events that occur after the
date the forward-looking statements are made.
Company Contact: Jeanne Chan Senior VP Tel. +888.676.4445
jchan@onehcorp.com Investor Relations & Corporate
Communications 888-676-4445 ir@onehcorp.com
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jun 2024 to Jul 2024
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
From Jul 2023 to Jul 2024